Allopregnanolone (Zuranolone) in Post-stroke Depression

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Post Stroke Depression

Interventions

DRUG

Zuranolone

Zuranolone is a neuroactive steroid that works by modulating the activity of the gamma-aminobutyric acid (GABA) receptor in the brain.

Trial Locations (1)

RECRUITING

Duke South Neurology Clinic 1L, Durham